Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06124261 · ClinicalTrials.gov registry record
Androgens and NAFLD Longitudinal Cohort Study
A clinical trial of NAFLD and NASH, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- 150
- Enrollment target
- 2
- Study locations
NCT06124261 is a study of NAFLD and NASH that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 150 participants, roughly in line with the 159-participant average among 26 other NAFLD trials with a reported enrollment target. The trial reports 2 study locations across 2 states.
The verdict
NCT06124261, a study of NAFLD and NASH, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
The researchers want to learn how androgens, a type of sex hormone, might affect nonalcoholic fatty liver (NAFLD) in young women over time. NAFLD happens when fat builds up in the liver which can cause damage to the liver such as inflammation or scarring. Young women with a condition called polycystic ovary syndrome (PCOS) have a high risk for NAFLD, and they often have high androgen levels too. So the researchers are recruiting young women with PCOS as well as those without PCOS, and will compare changes in NAFLD over time between young women with and without PCOS. This study is funded by the National Institutes of Health
Study Locations (2)
California
- University of California San Francisco - San Francisco
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-01-22 |
| Est. Completion | 2028-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06124261
The ClinicalTrials.gov registry entry for NCT06124261 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 159-participant average among 26 other NAFLD trials with a reported enrollment target. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with NAFLD appearing as the primary indexed condition, and to 0 interventions.
NCT06124261 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, North Carolina.
Frequently Asked Questions
What is clinical trial NCT06124261 about?
NCT06124261 is a clinical study titled "Androgens and NAFLD Longitudinal Cohort Study". The researchers want to learn how androgens, a type of sex hormone, might affect nonalcoholic fatty liver (NAFLD) in young women over time. NAFLD happens when fat builds up in the liver which can cause damage to the liver such as inflammation or scarring. Young women with a condition called polycys...
What is the current status of trial NCT06124261?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2024-01-22. Estimated completion is 2028-12.
What conditions does trial NCT06124261 study?
This clinical trial studies the following conditions: NAFLD, NASH, PCOS.
Who is sponsoring clinical trial NCT06124261?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06124261 being conducted?
This trial has 2 study locations across California, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NAFLD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pathogenesis of Pediatric Nonalcoholic Fatty Liver Disease (NAFLD)
RECRUITING
-
Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant
RECRUITING · Phase 2
-
Reversal of Lipid-Induced Insulin Resistance
RECRUITING · NA
-
Digoxin In NASH (CODIN)
RECRUITING · Phase 2
-
Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)
RECRUITING · Phase 3
-
Bicalutamide Therapy in Young Women With NAFLD and PCOS
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.